To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

Quarterly results

rupeeShow figures in :
rupeeShow figures in :

Quarterly results

Quarter ended on March 31, 2025Data in Crores of INR
Revenue
591.91+8.28% from last year
Operating profits
272.08+2.84% from last year
Net income
330.94+85.03% from last year

Financial reports

Data is unavailable

INCOME STATEMENTinfo2
Data in Crores of INR

Data is unavailable

BALANCE SHEETinfo2
Data in Crores of INR
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
Net worth4217.413595.543207.302864.412393.043395.493011.342683.202418.882163.501973.01658.41
Fixed assets723.62712.71749.25840.96864.74941.91853.86916.60867.08924.86944.3420.02
Debt2.502.502.502.502.502.502.502.502.502.502.50-
docView detailed balance sheet
arrow
CASH FLOWinfo2
Data in Crores of INR
FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Operating659.75256.84355.68667.08427.33323.1897.81331.80328.82345.48113.47132.45
Investing -71.3453.70-36.05-575.02-468.841530.3235.12-238.31-249.64-700.87-88.77102.66
Financing -205.34-235.14-345.79-180.51-1571.07-163.52-109.85-110.35-82.59-61.88-1.38-1360.17

Financial ratios

Profitability ratiosinfo2
ROA17.03%
ROE19.65%
ROCE26.21%
EPS167.78%
Net profit margin33.65%
Operating profit margin38.22%
Dividend per share165%
Operational ratiosinfo2
Quick ratio5.33%
Current ratio6.17%
Interest coverage120.54%
Assets turnover0.53%
Debt to equity
Valuation ratiosinfo2
P/E ratio177.36%
P/B ratio
Dividend yield3.1%
EV/EBITDA
Pfizer Limited is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The company has its own manufacturing facility at Goa. The company has various independent contract / third party manufacturers based across the country. It sells its products through independent distributors primarily in India. The company’s commercial operations are conducted through distinct business units that focus on clearly defined therapeutic areas. Between these business units, the company collectively addresses several therapy areas with a portfolio of many products that include therapeutics and vaccines.
personal

Grow your wealth with more research recommendations

+91